Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 2
2(40.0%)
5Total
N/A(3)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06746233Not ApplicableRecruiting

Drug-Eluting Balloon or Drug-Eluting Stent in Acute Myocardial Infarction: A Randomized Controlled Trial

Role: lead

NCT07360899Not ApplicableRecruiting

Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture

Role: lead

NCT02756000Not ApplicableCompleted

Timing of Complete Revascularization for Multivessel Coronary Artery Disease in STEMI

Role: collaborator

NCT03832660Phase 2Completed

Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy

Role: collaborator

NCT05366101Phase 2Completed

Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy

Role: collaborator

NCT04506047Unknown

Acute and Long-term Outcomes of Patients With Acute Myocardial Infarction Treated With PCI

Role: collaborator

All 6 trials loaded